• Something wrong with this record ?

Position paper on a simplified histopathological classification of basal cell carcinoma: results of the European Consensus Project

MT. Fernández-Figueras, J. Malvehi, P. Tschandl, A. Rutten, F. Rongioletti, L. Requena, H. Kittler, K. Kerl, D. Kazakov, B. Cribier, E. Calonje, J. André, W. Kempf, Study Group Collaborators (Validation Group)

. 2022 ; 36 (3) : 351-359. [pub] 20211221

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22010878

Grant support
PPRC-2019-15 European Academy of Dermatology and Venereology

BACKGROUND: Histopathological classification of basal cell carcinoma (BCC) has important prognostic and therapeutic implications, but reproducibility of BCC subtyping among dermatopathologists is poor. OBJECTIVES: To obtain a consensus paper on BCC classification and subtype definitions. METHODS: A panel of 12 recognized dermatopathologists (G12) from nine European countries used a modified Delphi method and evaluated 100 BCC cases uploaded to a website. The strategy involved five steps: (I) agreement on definitions for WHO 2018 BCC subtypes; (II) classification of 100 BCCs using the agreed definitions; (III) discussion on the weak points of the WHO classification and proposal of a new classification with clinical insights; (IV) re-evaluation of the 100 BCCs using the new classification; and (V) external independent evaluation by 10 experienced dermatopathologists (G10). RESULTS: A simplified classification unifying infiltrating, sclerosing, and micronodular BCCs into a single "infiltrative BCC" subtype improved reproducibility and was practical from a clinical standpoint. Fleiss' κ values increased for all subtypes, and the level of agreement improved from fair to moderate for the nodular and the unified infiltrative BCC groups, respectively. The agreement for basosquamous cell carcinoma remained fair, but κ values increased from 0.276 to 0.342. The results were similar for the G10 group. Delphi consensus was not achieved for the concept of trichoblastic carcinoma. In histopathological reports of BCC displaying multiple subtypes, only the most aggressive subtype should be mentioned, except superficial BCC involving margins. CONCLUSIONS: The three BCC subtypes with infiltrative growth pattern, characteristically associated with higher risk of deep involvement (infiltrating, sclerosing, and micronodular), should be unified in a single group. The concise and encompassing term "infiltrative BCCs" can be used for these tumors. A binary classification of BCC into low-risk and high-risk subtypes on histopathological grounds alone is questionable; correlation with clinical factors is necessary to determine BCC risk and therapeutic approach.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010878
003      
CZ-PrNML
005      
20220506130051.0
007      
ta
008      
220425s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jdv.17849 $2 doi
035    __
$a (PubMed)34931722
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Fernández-Figueras, M T $u Department of Pathology, Hospital Universitari General de Catalunya, Grupo Quironsalud & Universitat Internacional de Catalunya, Sant Cugat del Vallés, Spain $1 https://orcid.org/0000000223667110
245    10
$a Position paper on a simplified histopathological classification of basal cell carcinoma: results of the European Consensus Project / $c MT. Fernández-Figueras, J. Malvehi, P. Tschandl, A. Rutten, F. Rongioletti, L. Requena, H. Kittler, K. Kerl, D. Kazakov, B. Cribier, E. Calonje, J. André, W. Kempf, Study Group Collaborators (Validation Group)
520    9_
$a BACKGROUND: Histopathological classification of basal cell carcinoma (BCC) has important prognostic and therapeutic implications, but reproducibility of BCC subtyping among dermatopathologists is poor. OBJECTIVES: To obtain a consensus paper on BCC classification and subtype definitions. METHODS: A panel of 12 recognized dermatopathologists (G12) from nine European countries used a modified Delphi method and evaluated 100 BCC cases uploaded to a website. The strategy involved five steps: (I) agreement on definitions for WHO 2018 BCC subtypes; (II) classification of 100 BCCs using the agreed definitions; (III) discussion on the weak points of the WHO classification and proposal of a new classification with clinical insights; (IV) re-evaluation of the 100 BCCs using the new classification; and (V) external independent evaluation by 10 experienced dermatopathologists (G10). RESULTS: A simplified classification unifying infiltrating, sclerosing, and micronodular BCCs into a single "infiltrative BCC" subtype improved reproducibility and was practical from a clinical standpoint. Fleiss' κ values increased for all subtypes, and the level of agreement improved from fair to moderate for the nodular and the unified infiltrative BCC groups, respectively. The agreement for basosquamous cell carcinoma remained fair, but κ values increased from 0.276 to 0.342. The results were similar for the G10 group. Delphi consensus was not achieved for the concept of trichoblastic carcinoma. In histopathological reports of BCC displaying multiple subtypes, only the most aggressive subtype should be mentioned, except superficial BCC involving margins. CONCLUSIONS: The three BCC subtypes with infiltrative growth pattern, characteristically associated with higher risk of deep involvement (infiltrating, sclerosing, and micronodular), should be unified in a single group. The concise and encompassing term "infiltrative BCCs" can be used for these tumors. A binary classification of BCC into low-risk and high-risk subtypes on histopathological grounds alone is questionable; correlation with clinical factors is necessary to determine BCC risk and therapeutic approach.
650    12
$a bazocelulární karcinom $x patologie $7 D002280
650    _2
$a konsensus $7 D032921
650    _2
$a lidé $7 D006801
650    _2
$a resekční okraje $7 D000072662
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    12
$a nádory kůže $x patologie $7 D012878
655    _2
$a časopisecké články $7 D016428
700    1_
$a Malvehi, J $u Department of Dermatology, Hospital Clínic de Barcelona (Melanoma Unit), University of Barcelona, IDIBAPS, Barcelona & CIBERER, Barcelona, Spain
700    1_
$a Tschandl, P $u Department of Dermatology, Medical University of Vienna, Vienna, Austria
700    1_
$a Rutten, A $u Dermatopathology Practice Friedrichshafen/Lake Constance, Friedrichshafen, Germany
700    1_
$a Rongioletti, F $u Dermatology Clinic, IRCCS San Raffaele Hospital, Vita Salute University, Milan, Italy
700    1_
$a Requena, L $u Department of Dermatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain $1 https://orcid.org/0000000210454810
700    1_
$a Kittler, H $u Department of Dermatology, Medical University of Vienna, Vienna, Austria
700    1_
$a Kerl, K $u Department of Dermatology, University Hospital Zürich, Zürich, Switzerland
700    1_
$a Kazakov, D $u Sikl's Department of Pathology, Medical Faculty in Pilsen, Charles University in Prague, Pilsen, Czech Republic
700    1_
$a Cribier, B $u Dermatology Department University Hospital, Strasbourg, France
700    1_
$a Calonje, E $u St John's Institute of Dermatology, St Thomas Hospital, London, UK
700    1_
$a André, J $u Department of Dermatology, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium
700    1_
$a Kempf, W $u Kempf Pfaltz Histologische Diagnostik, Zurich, Switzerland $u Department of Dermatology, University Hospital Zurich, Zürich, Switzerland $1 https://orcid.org/0000000265528629
710    2_
$a Study Group Collaborators (Validation Group)
773    0_
$w MED00002983 $t Journal of the European Academy of Dermatology and Venereology : JEADV $x 1468-3083 $g Roč. 36, č. 3 (2022), s. 351-359
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34931722 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130043 $b ABA008
999    __
$a ok $b bmc $g 1788812 $s 1162076
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 36 $c 3 $d 351-359 $e 20211221 $i 1468-3083 $m Journal of the European Academy of Dermatology and Venereology $n J Eur Acad Dermatol Venerol $x MED00002983
GRA    __
$a PPRC-2019-15 $p European Academy of Dermatology and Venereology
LZP    __
$a Pubmed-20220425
Back

Find record

Citation metrics

Archiving options